Karen Fusaro

Karen Fusaro has extensive work experience in the pharmaceutical industry. Karen is currently the SVP of Clinical Operations at Seelos Therapeutics, Inc. Before that, they held the same role at Antios Therapeutics from April 2021 to August 2022. Prior to their role at Antios Therapeutics, they worked at Melinta Therapeutics as the Vice President of Clinical and Regulatory Operations from December 2019 to April 2021, and as the Vice President of Clinical Operations from January 2018 to December 2019. Earlier in their career, they served as the Senior Director of Clinical Project Management at The Medicines Company from August 2012 to January 2018, and as the Associate Director of Clinical Operations at Purdue Pharma from June 2011 to August 2012. Karen also worked as an Associate Director at Novartis from December 2008 to May 2011, and as the Assistant Director of Clinical Operations at GlaxoSmithKline from 2000 to 2008. Their career started at Lineberry Research Associates, where they worked as a Lead CRA from 1997 to 2000.

Karen Fusaro attended Binghamton University from 1991 to 1995 for an unspecified degree and field of study.